Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005358 220002100 1.62 null null 2014-07-03 2014-07-03 Cytarabine Low Dose N N 220028015 CYTARABINE
220005359 220002100 1.75 60 Curative (C) 2013-08-19 2013-08-19 AML17 TRIAL Y null 220028015 AML17 TRIAL
220005360 220002101 1.56 78 Curative (C) 2017-10-28 2017-10-30 AML17 TRIAL 1 null 220028022 AML17 TRIAL
220005361 220002102 null null null 2017-10-29 2017-10-30 Cytarabine Low Dose N N 220028023 CYTARABINE
220005362 220011132 1.7 89.25 Curative (C) 2013-07-24 2013-07-25 Trial Unspecified 1 N 220028027 TRIAL
220005363 220011132 1.6 0 Disease modification (D) 2014-11-04 2014-11-05 Trial Unspecified Y N 220028027 TRIAL
220005364 220011132 1.74 0 null 2015-01-06 2015-01-07 CYTARABINE null null 220028027 CYTARABINE
220005365 220011132 1.75 0 Palliative (P) 2017-05-09 2017-05-09 Cytarabine Low Dose N N 220028027 CYTARABINE
220005366 220002103 1.66 null Curative (C) 2014-12-28 2014-12-28 AML17 TRIAL Y N 220028037 AML17 TRIAL
220005367 220002103 null 74.4 Curative (C) 2016-02-08 2016-02-08 Trial Unspecified Y N 220028037 TRIAL
220005368 220002104 1.79 null Disease modification (D) 2016-11-03 2016-11-03 Trial Unspecified N N 220028043 TRIAL
220005369 220002104 1.61 69.4 Curative (C) 2016-02-24 2016-02-24 AML17 TRIAL N N 220028043 AML17 TRIAL
220005375 220021218 1.88 96 Curative (C) 2015-03-06 2015-03-06 AML17 TRIAL N null 220028050 AML17 TRIAL
220005376 220002106 1.47 60.5 Curative (C) 2017-09-28 2017-09-28 Trial Unspecified 1 N 220028053 TRIAL
220005377 220002106 1.7 null Palliative (P) 2016-02-02 2016-02-02 LI-1 TRIAL 01 N 220028053 TRIAL
220005378 220002106 1.76 null Not known (9) 2013-11-07 2013-11-19 CYTARABINE 2 null 220028053 CYTARABINE
220005379 220002107 0 89.4 Not known (9) 2016-01-12 2016-02-17 Trial Unspecified Y N 220028057 TRIAL
220005380 220002108 1.64 null Not known (9) 2013-07-18 2013-07-18 Trial Unspecified Y N 220028058 TRIAL
220005381 220002109 null 106.6 Curative (C) 2016-02-22 2016-02-26 AML17 TRIAL Y N 220028059 AML17 TRIAL
220005382 220002109 1.9 null Curative (C) 2013-12-13 2013-12-13 AML17 TRIAL 02 null 220028059 AML17 TRIAL
220005383 220002109 1.79 65.4 Palliative (P) 2016-04-14 2016-04-14 Cytarabine low (10to20mg/m2) IV/SC 02 N 220028059 CYTARABINE
220005384 220018741 0 0 Curative (C) 2013-10-08 2013-10-08 Trial Unspecified Y N 220028063 TRIAL
220005385 220018741 1.62 93 null 2016-05-01 2016-05-01 AML17 TRIAL 01 N 220028063 AML17 TRIAL
220005386 220002110 1.63 60 Not known (9) 2017-07-24 2017-07-25 AML17 TRIAL N N 220028069 AML17 TRIAL
220005387 220002110 1.8 144.7 Curative (C) 2014-12-21 2014-12-21 AML17 TRIAL N N 220028069 AML17 TRIAL
220005388 220002110 null null Curative (C) 2016-11-18 2016-11-25 AML17 TRIAL Y N 220028069 AML17 TRIAL
220005389 220002110 1.71 72.3 Palliative (P) 2015-10-19 2015-10-20 Trial Unspecified N N 220028069 TRIAL
220005390 220002110 1.63 null Palliative (P) 2017-10-15 2017-10-15 Cytarabine Low Dose N N 220028069 CYTARABINE
220005391 220002110 1.62 43.8 Curative (C) null 2016-03-24 AML17 TRIAL 02 N 220028069 AML17 TRIAL
220005392 220002110 1.8 91 Curative (C) 2015-08-10 2015-08-10 AML17 TRIAL N N 220028069 AML17 TRIAL
220005393 220002110 0 95.2 Palliative (P) 2016-05-01 2016-05-03 Cytarabine Low Dose 02 N 220028069 CYTARABINE
220005394 220002110 1.63 null Curative (C) 2013-01-17 2013-01-17 CYTARABINE 2 N 220028069 CYTARABINE
220005395 220002111 1.76 101 Palliative (P) null 2017-11-22 CYTARABINE null null 220028095 CYTARABINE
220005396 220002111 0 111.6 Palliative (P) 2017-12-28 2018-01-11 LI-1 TRIAL Y N 220028095 TRIAL
220005397 220002111 1.78 93.3 Curative (C) 2016-06-18 2016-06-19 Cytarabine Low Dose Y N 220028095 CYTARABINE
220005398 220002112 0 0 null 2017-02-01 2017-02-01 Trial Unspecified Y N 220028100 TRIAL
220005399 220002112 1.84 0 Palliative (P) null 2015-12-28 Cytarabine Intrathecal (any age) N N 220028100 CYTARABINE
220005400 220002112 1.71 73.2 null 2015-04-28 2015-04-28 Trial Unspecified 01 N 220028100 TRIAL
220005401 220002113 1.54 85.7 Palliative (P) 2017-06-05 2017-06-05 Cytarabine Low Dose 2 null 220028106 CYTARABINE
220005402 220002113 1.77 0 Disease modification (D) 2015-08-10 2015-08-15 Cytarabine Low Dose N N 220028106 CYTARABINE
220005403 220002113 null null Disease modification (D) 2015-09-14 2015-09-21 Cytarabine low (10to20mg/m2) IV/SC 2 N 220028106 CYTARABINE
220005404 220002113 null 84.6 null 2014-12-13 2014-12-13 CYTARABINE N N 220028106 CYTARABINE
220005405 220002113 1.68 71 Curative (C) 2017-08-20 2017-08-20 AML17 TRIAL N N 220028106 AML17 TRIAL
220005406 220002114 1.67 64.3 Curative (C) 2016-06-20 2016-06-20 AML17 TRIAL 02 N 220028118 AML17 TRIAL
220005407 220002114 null 81.2 null null 2015-09-09 Cytarabine low (10to20mg/m2) IV/SC null null 220028118 CYTARABINE
220005408 220002114 0 84.4 Palliative (P) 2016-01-09 2016-01-11 Trial Unspecified 01 N 220028118 TRIAL
220005409 220002114 null 78 Disease modification (D) 2017-11-05 2017-11-06 Cytarabine Low Dose 01 null 220028118 CYTARABINE
220005410 220002115 1.57 87 Curative (C) 2015-09-21 2015-09-21 AML17 TRIAL 02 N 220028127 AML17 TRIAL
220005411 220011143 null 52.4 Disease modification (D) 2013-06-29 2013-06-29 CYTARABINE N N 220028129 CYTARABINE
220005412 220011143 1.73 64.3 Curative (C) 2015-01-05 2015-01-08 AML17 TRIAL 01 N 220028129 AML17 TRIAL